Annual Accounts Payable:
$9.62M-$1.04M(-9.73%)Summary
- As of today, BBIO annual accounts payable is $9.62 million, with the most recent change of -$1.04 million (-9.73%) on December 31, 2024.
- During the last 3 years, BBIO annual accounts payable has fallen by -$2.27 million (-19.07%).
- BBIO annual accounts payable is now -28.80% below its all-time high of $13.51 million, reached on December 31, 2018.
Performance
BBIO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Payable:
$26.13M-$1.39M(-5.05%)Summary
- As of today, BBIO quarterly accounts payable is $26.13 million, with the most recent change of -$1.39 million (-5.05%) on June 30, 2025.
- Over the past year, BBIO quarterly accounts payable has increased by +$8.01 million (+44.18%).
- BBIO quarterly accounts payable is now -5.05% below its all-time high of $27.52 million, reached on March 31, 2025.
Performance
BBIO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BBIO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -9.7% | +44.2% |
| 3Y3 Years | -19.1% | +197.2% |
| 5Y5 Years | +8.7% | +103.6% |
BBIO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -19.1% | at low | -5.0% | +574.6% |
| 5Y | 5-Year | -19.1% | +8.7% | -5.0% | +574.6% |
| All-Time | All-Time | -28.8% | +410.2% | -5.0% | +574.6% |
BBIO Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $26.13M(-5.1%) |
| Mar 2025 | - | $27.52M(+186.2%) |
| Dec 2024 | $9.62M(-9.7%) | $9.62M(-28.0%) |
| Sep 2024 | - | $13.36M(-26.3%) |
| Jun 2024 | - | $18.13M(+283.4%) |
| Mar 2024 | - | $4.73M(-55.6%) |
| Dec 2023 | $10.65M(-7.8%) | $10.65M(+138.3%) |
| Sep 2023 | - | $4.47M(+15.4%) |
| Jun 2023 | - | $3.87M(-5.0%) |
| Mar 2023 | - | $4.08M(-64.7%) |
| Dec 2022 | $11.56M(-2.7%) | $11.56M(+13.8%) |
| Sep 2022 | - | $10.16M(+15.5%) |
| Jun 2022 | - | $8.79M(-13.0%) |
| Mar 2022 | - | $10.11M(-15.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $11.88M(+32.9%) | $11.88M(-1.3%) |
| Sep 2021 | - | $12.04M(-46.1%) |
| Jun 2021 | - | $22.33M(+115.9%) |
| Mar 2021 | - | $10.34M(+15.6%) |
| Dec 2020 | $8.95M(+1.1%) | $8.95M(-9.1%) |
| Sep 2020 | - | $9.84M(-23.3%) |
| Jun 2020 | - | $12.84M(-1.9%) |
| Mar 2020 | - | $13.09M(+47.8%) |
| Dec 2019 | $8.85M(-34.5%) | $8.85M(-13.8%) |
| Sep 2019 | - | $10.27M(-36.1%) |
| Jun 2019 | - | $16.07M(+30.1%) |
| Mar 2019 | - | $12.34M(-8.6%) |
| Dec 2018 | $13.51M(+616.7%) | $13.51M |
| Dec 2017 | $1.89M | - |
FAQ
- What is BridgeBio Pharma, Inc. annual accounts payable?
- What is the all-time high annual accounts payable for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual accounts payable year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly accounts payable?
- What is the all-time high quarterly accounts payable for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly accounts payable year-on-year change?
What is BridgeBio Pharma, Inc. annual accounts payable?
The current annual accounts payable of BBIO is $9.62M
What is the all-time high annual accounts payable for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual accounts payable is $13.51M
What is BridgeBio Pharma, Inc. annual accounts payable year-on-year change?
Over the past year, BBIO annual accounts payable has changed by -$1.04M (-9.73%)
What is BridgeBio Pharma, Inc. quarterly accounts payable?
The current quarterly accounts payable of BBIO is $26.13M
What is the all-time high quarterly accounts payable for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly accounts payable is $27.52M
What is BridgeBio Pharma, Inc. quarterly accounts payable year-on-year change?
Over the past year, BBIO quarterly accounts payable has changed by +$8.01M (+44.18%)